Patients with lupus nephritis complicated by thrombotic microangiopathy tend to have high death risk and poor renal outcomes. They need vital and effective therapies.

No increased risk for thrombosis or bleeding seen with concurrent use of enzalutamide, apalutamide, or abiraterone with DOACs.

Prasad's stint included several controversial vaccine decisions; the FDA is now searching for a new head for its vaccine division. (HealthDay News) — Dr. Vinay Prasad, who leads the U.S. Food and Drug ...

Contemporary donation after circulatory death donors are more medically complex than those from prior eras.

Investigators sought to determine if the gemcitabine intravesical system plus intravenous cetrelimab could improve survival for patients with muscle-invasive bladder cancer who did not receive radical ...

Adults with overweight or obesity regain much of their lost weight after cessation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to a re ...

Authors say individuals with COVID-19, particularly those at high risk for kidney disease, may need additional monitoring of kidney function.

In this phase 2 study, researchers aimed to evaluate the effectiveness of tyrosine kinase inhibition in relapsed or refractory germ cell tumors.

(HealthDay News) — Sleeping for seven hours and 18 minutes every night may help ward off the risk for insulin resistance, according to a study published online March 3 in BMJ Open Diabetes Research & ...

Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

Prevalence of hypertension, diabetes, and obesity estimated to increase, while hypercholesterolemia set to decline.

Investigators are exploring whether combinational therapies can improve survival for patients with renal cell carcinoma or muscle-invasive bladder cancer.